DR. MEENAN & PARTNERS
WHITEHOUSE MEDICAL GROUP PRAC, WHITEHOUSE MEDICAL GROUP PRAC, UNIT 29A, 1ST FLR ABBEYCENTRE, LONGWOOD ROAD, NEWTOWNABBEY
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 9 | 11 | 81.8% | |
| HF 4 | 2011 | 11 | 13 | 84.6% | |
| HF 4 | 2012 | 9 | 12 | 75.0% | |
| HF 4 | 2013 | 6 | 7 | 85.7% | |
| HF004 | 2014 | 0 | 0 | NA% | |
| HF004 | 2015 | None | None | NA% | |
| HF004 | 2016 | None | None | NA% | |
| HF004 | 2017 | 9 | 9 | 100.0% | |
| HF004 | 2018 | 8 | 9 | 88.9% | |
| HF004 | 2019 | 16 | 18 | 88.9% | |
| HF004 | 2020 | 20 | 22 | 90.9% | |
| HF004 | 2021 | 25 | 27 | 92.6% |
